Project Updates
Genentech's Biologics Manufacturing Facility, Oceanside, US
Location: Oceanside, California
Project type: Commercial biologics manufacturing facility
Expected Start of Operations: Early 2025
Owner: Genentech
Genentech, a member of Roche Group, will build a next-generation biologics manufacturing facility at its existing campus in Oceanside, California, for sustainable production of small-batch commercial biologics. A ground-breaking ceremony for the new manufacturing facility took place in February 2023.
BioNTech mRNA Vaccine Manufacturing Facility, Rwanda
Location: Kigali, Rwanda
Project type: Vaccine manufacturing facility
Start of Construction: June 2022
Owner: BioNTech
BioNTech is building its first modular mRNA vaccine manufacturing facility in Kigali, Rwanda, to promote sustainable vaccine production and end-to-end vaccine supply in African Union member states. The project is expected to create around 100 jobs by 2024.
Abzena’s cGMP Biologics Manufacturing Facility, Sanford, US
Location: Sanford, North Carolina
Project type: Biologics manufacturing site
Estimated Investment: $213m
Area: 120,0002
Abzena is building a current good manufacturing practice (cGMP) manufacturing facility for mammalian biologics in Sanford, North Carolina. The facility will expand the company’s manufacturing capacity to meet customer demand. Abzena’s new manufacturing site is expected to create 325 local jobs.
